Trials / Completed
CompletedNCT00212602
ONO-7436 Phase II Study in Japan
ONO-7436 Phase II Study - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of ONO-7436 for the Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting in Japan
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 420 (planned)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the efficacy and safety of ONO-7436 for the prevention of cancer chemotherapy-induced nausea and vomiting in patients with malignant tumor
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-7436 |
Timeline
- Start date
- 2005-08-01
- First posted
- 2005-09-21
- Last updated
- 2012-06-14
Locations
9 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00212602. Inclusion in this directory is not an endorsement.